Critical ligand binding reagent preparation/selection: when specificity depends on reagents.
Throughout the life cycle of biopharmaceutical products, bioanalytical support is provided using ligand binding assays to measure the drug product for pharmacokinetic, pharmacodynamic, and immunogenicity studies. The specificity and selectivity of these ligand binding assays are highly dependent on the ligand binding reagents. Thus the selection, characterization, and management processes for ligand binding reagents are crucial to successful assay development and application. This report describes process considerations for selection and characterization of ligand binding reagents that are integral parts of the different phases of assay development. Changes in expression, purification, modification, and storage of the ligand binding reagents may have a profound effect on the ligand binding assay performance. Thus long-term management of the critical ligand binding assay reagents is addressed including suggested characterization criteria that allow ligand binding reagents to be used in as consistent a manner as possible. Examples of challenges related to the selection, modification, and characterization of ligand binding reagents are included.
Rup
Bonita
B
Bioanalytical Research & Development, Drug Safety & Metabolism, Wyeth Research, Andover, MA 01867, USA.
O'Hara
Denise
D
D000911:Antibodies, Monoclonal / Q000737:chemistry*; D007118:Immunoassay / Q000379:methods; D007202:Indicators and Reagents / Q000737:chemistry / Q000592:standards; D008024:Ligands; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010599:Pharmacokinetics; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D000911:Antibodies, Monoclonal; D007202:Indicators and Reagents; D008024:Ligands; D004364:Pharmaceutical Preparations